MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$611M
AUM Growth
+$33.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1 +$21.2M
2 +$7.29M
3 +$7.23M
4
SLNO icon
Soleno Therapeutics
SLNO
+$6.76M
5
LQDA icon
Liquidia Corp
LQDA
+$4.55M

Top Sells

1 +$23M
2 +$14.8M
3 +$14.8M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$12.3M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$10.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$13.6B
$46.1M 7.54%
100,415
CGEM icon
2
Cullinan Oncology
CGEM
$672M
$45.4M 7.42%
7,648,268
RNA icon
3
Avidity Biosciences
RNA
$10.8B
$33.1M 5.42%
760,022
TRVI icon
4
Trevi Therapeutics
TRVI
$1.69B
$31.2M 5.1%
3,406,955
EWTX icon
5
Edgewise Therapeutics
EWTX
$2.76B
$27.9M 4.57%
1,720,741
PTCT icon
6
PTC Therapeutics
PTCT
$6.9B
$26.9M 4.41%
438,477
ZLAB icon
7
Zai Lab
ZLAB
$2.26B
$25.3M 4.13%
745,060
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.72B
$21.2M 3.46%
+1,375,674
ORIC icon
9
Oric Pharmaceuticals
ORIC
$1.16B
$20.8M 3.4%
1,729,378
TARS icon
10
Tarsus Pharmaceuticals
TARS
$3.39B
$20.3M 3.32%
341,496
XENE icon
11
Xenon Pharmaceuticals
XENE
$3.46B
$20.2M 3.31%
503,398
+180,000
STOK icon
12
Stoke Therapeutics
STOK
$1.77B
$18.6M 3.04%
789,698
DYN icon
13
Dyne Therapeutics
DYN
$3.13B
$18.3M 3%
1,446,361
CMPX icon
14
Compass Therapeutics
CMPX
$1.03B
$17.8M 2.91%
5,075,970
-546,535
ALKS icon
15
Alkermes
ALKS
$4.88B
$16.5M 2.7%
549,262
VERA icon
16
Vera Therapeutics
VERA
$2.16B
$16.4M 2.68%
563,075
NTRA icon
17
Natera
NTRA
$33B
$15.9M 2.61%
98,924
JANX icon
18
Janux Therapeutics
JANX
$2.05B
$15M 2.46%
614,282
RVMD icon
19
Revolution Medicines
RVMD
$15B
$14.7M 2.41%
315,722
CNTX icon
20
Context Therapeutics
CNTX
$103M
$14.2M 2.33%
14,705,882
SRPT icon
21
Sarepta Therapeutics
SRPT
$2.24B
$13.5M 2.21%
700,000
+378,304
SPRY icon
22
ARS Pharmaceuticals
SPRY
$943M
$13.1M 2.14%
1,303,399
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$370M
$12.7M 2.08%
3,903,381
+300
RLAY icon
24
Relay Therapeutics
RLAY
$1.37B
$11.9M 1.95%
2,282,680
RARE icon
25
Ultragenyx Pharmaceutical
RARE
$3.35B
$11.9M 1.95%
395,700